Evening Primrose Oil (PMS).

EPA slows the delta-5 desaturase step so more DGLA is held at the series-1 eicosanoid arm. That is the same arm GLA is supplied to reach.

The oil is highly unsaturated and needs a chain-breaking antioxidant to stay intact. Tocopherol is included in essentially every evening primrose softgel for that reason.

Zinc status sets delta-6 desaturase activity, the enzyme that converts linoleic acid to GLA. Adequate zinc keeps the endogenous route working alongside the supplied GLA.

Ascorbate regenerates spent tocopherol back to its active form. The pair keeps the polyunsaturated oil from peroxidising.

GLA feeds prostaglandin E1, which lowers normal platelet aggregation, and ginkgolides block platelet activating factor. The two effects add on the same physiology.

Garlic sulfur compounds independently damp normal platelet aggregation. Stacked with a GLA oil the effect is additive.

Cholecalciferol needs dietary lipid to enter micelles for uptake. The evening primrose softgel supplies that fat directly.

Gamma-linolenic acid is the compound evening primrose oil is taken for, present at roughly seven to ten percent of the oil. Adding isolated GLA to the same formula raises the same active, so the two are one dose and not two. Any total GLA figure should be read across both.

Delta-6 desaturase, the rate-limiting enzyme that converts linoleic acid to GLA, depends on adequate pyridoxine, zinc and magnesium status. Evening primrose oil supplies GLA already made, so it bypasses that enzyme, but the next elongation and desaturation steps still sit in the same nutrient-dependent pathway. B6 is also long-standing formulation practice in cyclical comfort products.

Magnesium is required by the desaturase and elongase steps that handle GLA downstream, and it is one of the standard companions in formulas aimed at comfort across the menstrual cycle. The cofactor relationship is settled biochemistry; the cyclical comfort use rests on magnesium's own literature, not on the oil's.

GLA elongates to dihomo-gamma-linolenic acid, and DGLA can then be desaturated onward to arachidonic acid by delta-5 desaturase. EPA restrains that delta-5 step, so co-dosing tends to hold more of the GLA at the DGLA stage. This is why the two are often deliberately combined rather than kept apart, and it is a pathway argument rather than an outcome trial.

Linoleic acid is the substrate that feeds the same delta-6 desaturase and elongase machinery GLA uses, and it is by far the larger part of evening primrose oil itself. A large separate linoleic load competes for the same enzymes. In practice this means the GLA percentage, not the total oil volume, is the number that matters.

Alpha-linolenic acid from flax competes with linoleic acid and GLA for delta-6 desaturase and the shared elongases. Combining the two oils splits enzyme capacity between the omega-6 and omega-3 branches. This is a well-described competition in fatty acid metabolism and not a reason to avoid either.

Borage seed oil carries GLA at roughly twice to three times the share evening primrose oil does. Running both means one active from two sources, so the combined GLA figure is what should be counted. The oils differ in their other fatty acids and in their minor constituents.

DGLA-derived eicosanoids tend to dampen platelet aggregation, and nattokinase acts on fibrin and clot handling. The directions add up, which is a caution to flag for anyone on anticoagulant or antiplatelet medication or facing surgery, not a benefit to sell. No combination trial quantifies the overlap.

Willow bark supplies salicylates, which inhibit platelet cyclooxygenase. Adding a GLA-rich oil that shifts eicosanoid balance in the same direction stacks two antiplatelet influences. Worth stating plainly on a page where the oil is already paired with fish oil, garlic and ginkgo.

Calcium is one of the better-studied single nutrients for comfort across the menstrual cycle and is routinely formulated alongside evening primrose oil. The two mechanisms are unrelated, which is the point of combining them. The calcium half carries the stronger human evidence of the pair.

Chasteberry acts on the prolactin and dopaminergic side while a GLA-rich oil acts on eicosanoid balance, so the two are combined for different reasons in the same formula. This row records the pairing and its rationale. No trial has tested the combination.

Black cohosh appears with evening primrose oil in women's formulas aimed at cyclical and transitional comfort, with a mechanism that is still debated and unrelated to fatty acid metabolism. There is no shared biochemistry and no combination data. Recorded as a formulation pairing.